Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study - Top-Institutions - MDSpire

Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study

  • By

  • Frederique St-Pierre

  • Subodh Bhatta

  • Peter G. Doukas

  • Madeline Jenkin

  • Kaitlin Annunzio

  • Alexandra E. Rojek

  • Alyssa Gibson

  • Yun Kyoung Tiger

  • Brittany McCall

  • Khaled Alhamad

  • Alec Hansen

  • Juan P. Alderuccio

  • Olutobi Adewale

  • Keem Patel

  • Asaad Trabolsi

  • Izidore S. Lossos

  • Lindsey Fitzgerald

  • Thomas A. Ollila

  • Matthew J. Matasar

  • Justin Kline

  • Reem Karmali

  • Narendranath Epperla

  • June 21, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy

  • #2

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

Original Source(s)

Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study

  • by Frederique St-Pierre, Subodh Bhatta, Peter G. Doukas, Madeline Jenkin, Kaitlin Annunzio, Alexandra E. Rojek, Alyssa Gibson, Yun Kyoung Tiger, Brittany McCall, Khaled Alhamad, Alec Hansen, Juan P. Alderuccio, Olutobi Adewale, Keem Patel, Asaad Trabolsi, Izidore S. Lossos, Lindsey Fitzgerald, Thomas A. Ollila, Matthew J. Matasar, Justin Kline, Reem Karmali, Narendranath Epperla

  • June 21, 2025

Related Content

Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies

Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

Preet M. Chaudhary, MD, PhD, discusses the repeat ranking of the USC Norris Blood and Marrow Transplant and Cell Therapy Program as one of the nation’s elite allogeneic transplant programs with the highest survival outcomes.

  • by

  • February 13, 2026

  • 12 min